{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:17:00Z","timestamp":1778897820932,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R56HL171301"],"award-info":[{"award-number":["R56HL171301"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R35HL155657"],"award-info":[{"award-number":["R35HL155657"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rpth.2025.103319","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:28:22Z","timestamp":1767025702000},"page":"103319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemia"],"prefix":"10.1016","volume":"10","author":[{"given":"Sierra J.","family":"Archibald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana T.A.","family":"Sachetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Gangaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Mackman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-0524","authenticated-orcid":false,"given":"Yohei","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103319_bib1","first-page":"38","article-title":"Acute myeloid leukemia: a review","volume":"103","author":"Pelcovits","year":"2020","journal-title":"R I Med J (2013)"},{"key":"10.1016\/j.rpth.2025.103319_bib2","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.2024025409","article-title":"Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations","volume":"144","author":"D\u00f6hner","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103319_bib3","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1111\/jth.15074","article-title":"Management of hemostatic complications in acute leukemia: guidance from the SSC of the ISTH","volume":"18","author":"Wang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103319_bib4","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jtha.2024.03.020","article-title":"Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia","volume":"22","author":"Hisada","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103319_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40164-015-0018-x","article-title":"Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study","volume":"4","author":"Dicke","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.rpth.2025.103319_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1515\/CCLM.2010.311","article-title":"Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia","volume":"48","author":"Gao","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.rpth.2025.103319_bib7","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.V86.3.1072.1072","article-title":"Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid","volume":"86","author":"Falanga","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103319_bib8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/10245332.2018.1470069","article-title":"Characteristics of fibrinolytic disorders in acute promyelocytic leukemia","volume":"23","author":"Wang","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.rpth.2025.103319_bib9","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.2147\/OTT.S144438","article-title":"Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia","volume":"10","author":"Song","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.rpth.2025.103319_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.leukres.2010.05.022","article-title":"Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia","volume":"35","author":"Kim","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.rpth.2025.103319_bib11","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.thromres.2018.01.038","article-title":"Predictive factors of fatal bleeding in acute promyelocytic leukemia","volume":"164","author":"Mantha","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103319_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.thromres.2013.12.029","article-title":"Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia","volume":"133","author":"Thaler","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103319_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood.V71.1.242.242","article-title":"HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3","volume":"71","author":"Dalton","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103319_bib14","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.V77.5.1080.1080","article-title":"NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)","volume":"77","author":"Lanotte","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103319_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V92.1.143.413k18_143_151","article-title":"Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells","volume":"92","author":"Falanga","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103319_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3324\/haematol.2011.055343","article-title":"Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography","volume":"97","author":"Marchetti","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.103319_bib17","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1182\/bloodadvances.2023010466","article-title":"Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia","volume":"7","author":"Hisada","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103319_bib18","article-title":"Evaluation of four commercial ELISAs to measure tissue factor in human plasma","volume":"7","author":"Sachetto","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103319_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.thromres.2013.11.008","article-title":"Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state","volume":"133","author":"Gheldof","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103319_bib20","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1182\/blood.V87.8.3404.bloodjournal8783404","article-title":"Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice","volume":"87","author":"Zhang","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103319_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.19","article-title":"A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia","volume":"5","author":"Saland","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.rpth.2025.103319_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-9560-3-12","article-title":"Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes","volume":"3","author":"Sommeijer","year":"2005","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2025.103319_bib23","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1538-7836.2009.03448.x","article-title":"Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice","volume":"7","author":"Wang","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103319_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1160\/TH17-08-0596","article-title":"Contact system activation and cancer: new insights in the pathophysiology of cancer-associated thrombosis","volume":"118","author":"Campello","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103319_bib25","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1182\/blood-2012-01-402156","article-title":"Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer","volume":"119","author":"Wang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103319_bib26","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJM199904013401303","article-title":"Annexin II and bleeding in acute promyelocytic leukemia","volume":"340","author":"Menell","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103319_bib27","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2010-07-298851","article-title":"Regulation of S100A10 by the PML-RAR-alpha oncoprotein","volume":"117","author":"O'Connell","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103319_bib28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41375-018-0069-1","article-title":"Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin","volume":"32","author":"Lavall\u00e9e","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.rpth.2025.103319_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-2952(01)00848-6","article-title":"Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid","volume":"63","author":"Devy","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.rpth.2025.103319_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.leu.2400918","article-title":"Interferons and retinoids enhance and dexamethasone suppresses urokinase-mediated plasminogen activation in promyelocytic leukemia cells","volume":"12","author":"Mustjoki","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.rpth.2025.103319_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MOH.0000000000000880","article-title":"Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms","volume":"32","author":"Hisada","year":"2025","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2025.103319_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5045\/br.2013.48.4.250","article-title":"Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation","volume":"48","author":"Lee","year":"2013","journal-title":"Blood Res"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925006430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925006430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:52:57Z","timestamp":1778896377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925006430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2475037925006430"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103319","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103319"}}